Multidrug-resistant tuberculosis (MDR-TB) is a type of TB that does not respond to isoniazid and rifampicin. Delamanid is a recently approved drug for the treatment of MDR-TB. This study aims to examine the efficacy and safety...
Read MoreMultidrug-resistant TB (MDR-TB) is a type of tuberculosis that does not respond to at least isoniazid and rifampicin. The two routinely used anti-TB drugs. Combination therapy with multiple second-line drugs can be used, but it...
Read More
Written by Physician’s Weekly Blogger, Skeptical Scalpel Although at the time I wrote this...
Read More
Increased lung recruitability seen with alternating body position between supine and prone...
Read More
Devices may activate prematurely if the blue safety release is removed using sideways force
Read More
Likelihood of being cured, discharged higher for patients without versus with digestive symptoms
Read MoreAgency says it is still too early to know how severe this year’s flu season will be. MONDAY, Dec. 30, 2019 (HealthDay News) — Flu continues to spread throughout the United States and has reached elevated levels in...
Read More